Reuters Market Eye - Novartis India Ltd shares gained as much as 10.7 percent after parent Novartis AG said in a statement it will sell shares of its Indian unit via stock exchanges to reduce its holding.
The sale of shares in Novartis India is intended to comply with the regulation that at least 25 percent of private companies shares' must be held by public shareholders by June.
Novartis India would need to sell a 1.42 percent stake to comply with those norms.
Novartis India shares gain 2.5 percent after earlier falling to their lowest level since May 17, 2010.
India's Supreme Court is due to decide on April 1 whether Novartis AG's cancer treatment Glivec deserves a patent in the country.
(Reporting by Manoj Dharra)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app